IDENTIFICATION OF POTENT DUAL OREXIN RECEPTOR ANTAGONISTS

被引:0
作者
Coleman, Paul J. [1 ]
Schreier, John D. [1 ]
Cox, Christopher D. [1 ]
Breslin, Michael J. [1 ]
Whitman, David B. [1 ]
Roecker, Anthony J. [1 ]
Bogusky, Michael J. [1 ]
Bednar, Rodney A. [1 ]
Lemaire, Wei [1 ]
Bruno, Joseph C. [1 ]
Hartman, George D. [1 ]
McGaughey, Georgia B. [1 ]
Reiss, Duane R. [2 ]
Harrell, C. Meacham [2 ]
Doran, Scott M. [2 ]
Garson, Susan L. [2 ]
Kraus, Richard L. [2 ]
Li, Yuxing [2 ]
Prueksaritanont, Thomayant [3 ]
Li, Chunze [3 ]
Winrow, Christopher J. [2 ]
Koblan, Kenneth S. [2 ]
Renger, John J. [2 ]
机构
[1] Merck Res Labs, Dept Med Chem, West Point, PA USA
[2] Merck Res Labs, Dept Depress & Circadian Disorders, West Point, PA USA
[3] Merck Res Labs, Dept Drug Metab, West Point, PA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:10 / 11
页数:2
相关论文
共 50 条
[41]   GPCR structure-based drug discovery: Identification of dual orexin antagonists and orexin-1 selective antagonists for the treatment of insomnia and addiction disorders [J].
Christopher, John A. .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[42]   Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review [J].
Besterman, Aaron D. ;
Jeste, Shafali S. .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2023, 32 (03) :527-531
[43]   Novel therapeutic class for insomnia treatment: Dual orexin receptor antagonists - it is worth to prescribe it? [J].
Nogueira, J. ;
Ribeiro, R. ;
Mendes, S. ;
Gamito, A. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 :S515-S515
[44]   Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review [J].
Aaron D. Besterman ;
Shafali S. Jeste .
European Child & Adolescent Psychiatry, 2023, 32 :527-531
[45]   Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis [J].
Xue, Tao ;
Wu, Xin ;
Li, Jiaxuan ;
Chen, Shujun ;
Wang, Zilan ;
Tan, Xin ;
Wang, Zhong ;
Zhang, Jianguo .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[46]   The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold [J].
Gotter, Anthony L. ;
Winrow, Christopher J. ;
Brunner, Joseph ;
Garson, Susan L. ;
Fox, Steven V. ;
Binns, Jacquelyn ;
Harrell, Charles M. ;
Cui, Donghui ;
Yee, Ka Lai ;
Stiteler, Mark ;
Stevens, Joanne ;
Savitz, Alan ;
Tannenbaum, Pamela L. ;
Tye, Spencer J. ;
McDonald, Terrence ;
Yao, Leon ;
Kuduk, Scott D. ;
Uslaner, Jason ;
Coleman, Paul J. ;
Renger, John J. .
BMC NEUROSCIENCE, 2013, 14
[47]   Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators [J].
Anthony L Gotter ;
Susan L Garson ;
Joanne Stevens ;
Regina L Munden ;
Steven V Fox ;
Pamela L Tannenbaum ;
Lihang Yao ;
Scott D Kuduk ;
Terrence McDonald ;
Jason M Uslaner ;
Spencer J Tye ;
Paul J Coleman ;
Christopher J Winrow ;
John J Renger .
BMC Neuroscience, 15
[48]   Orexin receptor antagonists: a new treatment for insomnia? [J].
Riemann, Dieter ;
Spiegelhalder, Kai .
LANCET NEUROLOGY, 2014, 13 (05) :441-443
[49]   Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists [J].
Fujimoto, Tatsuhiko ;
Kunitomo, Jun ;
Tomata, Yoshihide ;
Nishiyama, Keiji ;
Nakashima, Masato ;
Hirozane, Mariko ;
Yoshikubo, Shin-ichi ;
Hirai, Keisuke ;
Marui, Shogo .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) :6414-6416
[50]   Opportunities and perspectives for developing orexin receptor antagonists [J].
Barnes, Nicholas M. .
FRONTIERS IN NEUROSCIENCE, 2014, 8